Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study starting Wednesday will be one of the world’s largest coronavirus vaccine studies so far, testing the shot in 60,000 volunteers in the U.S., South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru. A handful of other vaccines in the U.S. — including shots made by Moderna Inc. and Pfizer Inc. — and others in other countries are already in final-stage testing. Hopes are high that answers about at least one candidate being...
Full ArticleJohnson & Johnson begins final-stage testing on single-dose COVID-19 vaccine
WorldNews
0 shares
1 views
You might like
Related news coverage
COVID-19: Two lakh dead as Donald Trump vilifies science
Mid-Day
"I did the best I could," President Donald Trump said. Huddled with aides in the West Wing last week, his eyes fixed on Fox News,..
Advertisement
More coverage
Johnson & Johnson Begins Final Stage Of Testing For Its Single-Dose COVID-19 Vaccine
Daily Caller
Most expansive to occur so far
-
Late-stage study of first single-shot coronavirus vaccine begins in U.S.
Denver Post
-
Johnson & Johnson begins final phase of single-shot COVID-19 vaccine study
CBC.ca
-
Late-stage study of first single-shot vaccine begins in U.S.
Newsday
-
Late-stage study of first single-shot vaccine begins in US
SeattlePI.com